Breakthrough Chemistry, Inc. (BKTH)
0.208
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Breakthrough Chemistry Enterprise Value : 1.389M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.389M |
| August 21, 2026 | 1.389M |
| August 20, 2026 | 1.389M |
| August 19, 2026 | 1.389M |
| August 18, 2026 | 1.243M |
| August 17, 2026 | 1.243M |
| August 14, 2026 | 1.172M |
| August 13, 2026 | 1.206M |
| August 12, 2026 | 1.196M |
| August 11, 2026 | 1.408M |
| August 10, 2026 | 1.408M |
| August 07, 2026 | 1.506M |
| August 06, 2026 | 1.931M |
| August 05, 2026 | 1.966M |
| August 04, 2026 | 1.966M |
| August 03, 2026 | 1.966M |
| July 31, 2026 | 1.966M |
| July 30, 2026 | 2.085M |
| July 29, 2026 | 1.955M |
| July 28, 2026 | 2.086M |
| July 27, 2026 | 2.036M |
| July 24, 2026 | 2.059M |
| July 23, 2026 | 2.089M |
| July 22, 2026 | 1.904M |
| July 21, 2026 | 1.904M |
| Date | Value |
|---|---|
| July 20, 2026 | 1.471M |
| July 17, 2026 | 1.603M |
| July 16, 2026 | 1.78M |
| July 15, 2026 | 2.089M |
| July 14, 2026 | 1.798M |
| July 13, 2026 | 1.966M |
| July 10, 2026 | 2.032M |
| July 09, 2026 | 2.037M |
| July 08, 2026 | 2.032M |
| July 07, 2026 | 1.895M |
| July 06, 2026 | 2.167M |
| July 02, 2026 | 1.798M |
| July 01, 2026 | 2.283M |
| June 30, 2026 | 2.283M |
| June 29, 2026 | 1.330M |
| June 26, 2026 | 1.592M |
| June 25, 2026 | 1.593M |
| June 24, 2026 | 1.787M |
| June 23, 2026 | 1.517M |
| June 22, 2026 | 1.537M |
| June 18, 2026 | 1.603M |
| June 17, 2026 | 1.603M |
| June 16, 2026 | 1.495M |
| June 15, 2026 | 1.495M |
| June 12, 2026 | 1.982M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cardiac Biotech Solutions, Inc. | 7.343M |
| Precision Optics Corp., Inc. | 42.07M |
| Petros Pharmaceuticals, Inc. | -3.311M |
| RxSight, Inc. | 62.11M |
| Vyome Holdings, Inc. | 9.128M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.083M |
| Revenue (Quarterly) | 0.0025M |
| Total Expenses (Quarterly) | 1.085M |
| EPS Diluted (Quarterly) | -0.1113 |
| Profit Margin (Quarterly) | -43.31K% |
| Earnings Yield | -48.89% |
| Normalized Earnings Yield | -16.73 |